JP2007511492A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007511492A5 JP2007511492A5 JP2006538951A JP2006538951A JP2007511492A5 JP 2007511492 A5 JP2007511492 A5 JP 2007511492A5 JP 2006538951 A JP2006538951 A JP 2006538951A JP 2006538951 A JP2006538951 A JP 2006538951A JP 2007511492 A5 JP2007511492 A5 JP 2007511492A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- compound
- medicament
- prevention
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0326518.8A GB0326518D0 (en) | 2003-11-13 | 2003-11-13 | Anti-cancer compounds |
| PCT/GB2004/004769 WO2005049001A1 (en) | 2003-11-13 | 2004-11-12 | Anti-tumour terpene compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007511492A JP2007511492A (ja) | 2007-05-10 |
| JP2007511492A5 true JP2007511492A5 (https=) | 2007-09-27 |
Family
ID=29726508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538951A Withdrawn JP2007511492A (ja) | 2003-11-13 | 2004-11-12 | 抗腫瘍テルペン化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20070259056A1 (https=) |
| EP (1) | EP1682107B1 (https=) |
| JP (1) | JP2007511492A (https=) |
| KR (1) | KR20060121177A (https=) |
| CN (2) | CN1882319B (https=) |
| AT (1) | ATE439126T1 (https=) |
| AU (1) | AU2004290946B2 (https=) |
| CA (1) | CA2545717A1 (https=) |
| DE (1) | DE602004022578D1 (https=) |
| DK (1) | DK1682107T3 (https=) |
| GB (1) | GB0326518D0 (https=) |
| WO (1) | WO2005049001A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101849981B (zh) * | 2010-06-22 | 2011-11-23 | 南京中医药大学 | 一种具有抗妇科肿瘤作用的没药有效部位及其制备方法和其应用 |
| WO2012033634A2 (en) | 2010-09-09 | 2012-03-15 | Mary Kay Inc. | Topical skin care formulations comprising plant extracts |
| WO2018144954A1 (en) * | 2017-02-03 | 2018-08-09 | City Of Hope | Silica nanoparticle with an insoluble drug |
| WO2020033567A1 (en) * | 2018-08-07 | 2020-02-13 | University Of Florida Research Foundation | Methods and compositions for substituted arylcycloheptane analogs |
| CN110960518B (zh) * | 2019-12-31 | 2022-12-20 | 河南大学 | 金丝大菊提取物在制备抗肿瘤药物中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5190979A (en) * | 1988-06-24 | 1993-03-02 | Stephen Herman | Ozonides of terpenes and their medical uses |
| US6350784B1 (en) * | 1996-02-12 | 2002-02-26 | Meryl J. Squires | Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| US5602184A (en) * | 1993-03-03 | 1997-02-11 | The United States Of America As Represented By Department Of Health And Human Services | Monoterpenes, sesquiterpenes and diterpenes as cancer therapy |
| US5876728A (en) * | 1995-02-15 | 1999-03-02 | Howard David Kass | Natural composition extracted from plants used in the treatment of cancer |
| AUPO316796A0 (en) * | 1996-10-23 | 1996-11-14 | Hood, John James David | Essential oil |
| US6464839B1 (en) | 1997-04-14 | 2002-10-15 | Yuan Da International Group Limited | Beta-elemene, method to prepare the same and uses thereof |
| US6265639B1 (en) * | 1998-01-22 | 2001-07-24 | Washington State University Foundation | Gymnosperm nucleic acid molecules encoding sesquiterpene synthases and methods of use |
| FR2808196A1 (fr) | 2000-04-27 | 2001-11-02 | Andre Rougereau | Nouveaux medicaments a base de melanges de sesquiterpenes |
| FR2811899B1 (fr) * | 2000-07-20 | 2003-02-07 | Anne Marie Pierrette Giraud | Association d'huiles essentielles et applications therapeutiques |
| US6486706B2 (en) | 2000-12-06 | 2002-11-26 | Intel Corporation | Domino logic with low-threshold NMOS pull-up |
| EP1351678A2 (en) * | 2001-01-02 | 2003-10-15 | Elizabeth Shanahan-Prendergast | Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens |
| WO2002080951A1 (en) * | 2001-04-06 | 2002-10-17 | Synergistix Biotech, Inc. | Herbal extracts for the treatment of cancer |
| GB0210152D0 (en) * | 2002-05-02 | 2002-06-12 | Compton Developments Ltd | Use of plant materials |
| EP1587482A4 (en) * | 2003-01-31 | 2010-08-25 | Technion Res & Dev Foundation | INFLAMMATORY COMPOSITIONS AND ITS USES |
| US20050074509A1 (en) * | 2003-10-02 | 2005-04-07 | Data Medica Padova S.P.A. | Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components |
-
2003
- 2003-11-13 GB GBGB0326518.8A patent/GB0326518D0/en not_active Ceased
-
2004
- 2004-11-12 CN CN2004800336500A patent/CN1882319B/zh not_active Expired - Fee Related
- 2004-11-12 JP JP2006538951A patent/JP2007511492A/ja not_active Withdrawn
- 2004-11-12 KR KR1020067011566A patent/KR20060121177A/ko not_active Ceased
- 2004-11-12 AU AU2004290946A patent/AU2004290946B2/en not_active Ceased
- 2004-11-12 DK DK04798492T patent/DK1682107T3/da active
- 2004-11-12 WO PCT/GB2004/004769 patent/WO2005049001A1/en not_active Ceased
- 2004-11-12 EP EP04798492A patent/EP1682107B1/en not_active Expired - Lifetime
- 2004-11-12 CA CA002545717A patent/CA2545717A1/en not_active Abandoned
- 2004-11-12 DE DE602004022578T patent/DE602004022578D1/de not_active Expired - Lifetime
- 2004-11-12 AT AT04798492T patent/ATE439126T1/de not_active IP Right Cessation
- 2004-11-12 CN CN201010205334A patent/CN101862365A/zh active Pending
- 2004-11-12 US US10/579,135 patent/US20070259056A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008521928A5 (https=) | ||
| JP2009502743A5 (https=) | ||
| GB0215844D0 (en) | Organic compounds | |
| JP2017517506A5 (https=) | ||
| JP2006523216A5 (https=) | ||
| AU4550801A (en) | Herbal composition phy906 and its use in chemotheraphy | |
| JP2015508103A5 (https=) | ||
| CA2922684A1 (en) | Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases | |
| JP2015502926A5 (https=) | ||
| JP2009539994A5 (https=) | ||
| WO2006053049A3 (en) | Herbal composition phy906 and its use in chemotherapy | |
| JP2015527374A5 (https=) | ||
| WO2006047298A3 (en) | Eph receptor tumor biomarkers | |
| JP2008513510A5 (https=) | ||
| JP2015507020A5 (https=) | ||
| JP2015519347A5 (https=) | ||
| WO2006138608A3 (en) | Pharmaceutical compositions and use thereof | |
| JP2008524329A5 (https=) | ||
| JP2008536853A5 (https=) | ||
| EP1667716B8 (en) | Cytotoxicity mediation of cells evidencing surface expression of cd44 | |
| WO2009023955A8 (en) | Cytotoxicity mediation of cells evidencing surface expression of cd9 | |
| JP2007511492A5 (https=) | ||
| JP2009516719A5 (https=) | ||
| SI1803456T1 (sl) | Farmacevtski sestavki, ki obsegajo L-733060, za uporabo pri zdravljenju rakavih tumorjev | |
| EP1568383A3 (en) | Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment |